Box 1 Intensified iDES to support treatment policy change
100% adherence to the national treatment guidelines |
No stock-outs of drugs |
Additional training for treatment providers to ensure daily supervised drug intake |
Target to achieve > 90% of follow-up days |
iDES standard operating procedures are followed with increased frequency of monitoring |
Adequate patient support for follow-up visits (providing transport, etc.) |
Quality control on all microscopy slides |
Collection of all day 0 dried blood spots and at recurrence for PCR and molecular markers |
Follow-up of all treatment failures |
Integration of laboratory data and the results of molecular markers to the online system |